Literature DB >> 8609154

Expression of stem-cell factor and its receptor c-kit protein in normal testicular tissue and malignant germ-cell tumours.

C Bokemeyer1, M A Kuczyk, T Dunn, J Serth, K Hartmann, J Jonasson, T Pietsch, U Jonas, H J Schmoll.   

Abstract

The proto-oncogene c-kit and its ligand stem-cell factor (SCF) may play an important role in the development of normal and malignant testicular tissue. This study investigates the presence of SCF and c-kit protein in 32 orchiectomy specimens of patients with testicular cancer, in 5 specimens of normal testicular tissue and in three established non-seminomatous germ-cell cancer cell lines (H12.1, H32, 577ML) by an immunohistochemical approach. Out of 9 testicular cancer specimens classified as pure seminomas, 7 (78%) showed a strong immunohistochemical reaction for both SCF and c-kit protein on the surface of the tumour cells. Fourteen non-seminomatous germ-cell tumours composed of embryonal carcinoma were completely negative for both SCF and c-kit proteins and only faint positivity was found in 6 tumours (26%). Differentiated teratomatous structures within the specimens on non-seminomatous tumours showed a strong immunohistochemical reaction for SCF and c-kit protein in 8 of 11 (73%) cases. All three testicular cancer cell lines showed only faint staining reactions for c-kit protein and none for SCF. No secretion of SCF by the three lines in vitro was detected. The addition of high concentrations of SCF (100 ng/ml) to the testicular cancer cell lines in culture conditions without fetal calf serum resulted in a 1.4 to 3-fold growth stimulation compared to cell growth in serum-free medium alone. This effect was not detectable when the cells were cultured in serum-containing media. In the normal testicular tissue the germ-cells displayed a strong immunohistochemical reaction for c-kit protein while SCF positivity was found at the tubular membrane and on the surface of Sertoli cells. The SCF/c-kit system may possess a regulatory function in normal testicular tissue by possibly providing the microenvironment necessary for spermatogenesis. With the development of testicular cancer, this regulatory system seems to be lost, particularly in non-seminomatous germ-cell tumours. A growth-stimulatory effect of high concentrations of SCF on non-seminomatous testicular cancer cell lines can be detected only in culture conditions with serum-free media. The effects achievable by the combination of SCF with other growth factors need to be further studied, as well as the role of the c-kit/SCF regulatory system for normal spermatogenesis and its possible implications for the understanding and treatment of male infertility.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8609154     DOI: 10.1007/bf01261407

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  25 in total

1.  Cell lines of human germinal cancer.

Authors:  J Casper; H J Schmoll; U Schnaidt; C Fonatsch
Journal:  Int J Androl       Date:  1987-02

2.  Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.

Authors:  D J Slamon; W Godolphin; L A Jones; J A Holt; S G Wong; D E Keith; W J Levin; S G Stuart; J Udove; A Ullrich
Journal:  Science       Date:  1989-05-12       Impact factor: 47.728

3.  Effects of the steel gene product on mouse primordial germ cells in culture.

Authors:  I Godin; R Deed; J Cooke; K Zsebo; M Dexter; C C Wylie
Journal:  Nature       Date:  1991-08-29       Impact factor: 49.962

Review 4.  Proto-oncogenes and tumor suppressor genes in human urological malignancies.

Authors:  T G Strohmeyer; D J Slamon
Journal:  J Urol       Date:  1994-06       Impact factor: 7.450

5.  New colorimetric cytotoxicity assay for anticancer-drug screening.

Authors:  P Skehan; R Storeng; D Scudiero; A Monks; J McMahon; D Vistica; J T Warren; H Bokesch; S Kenney; M R Boyd
Journal:  J Natl Cancer Inst       Date:  1990-07-04       Impact factor: 13.506

6.  Nonhematopoietic tumor cell lines express stem cell factor and display c-kit receptors.

Authors:  A M Turner; K M Zsebo; F Martin; F W Jacobsen; L G Bennett; V C Broudy
Journal:  Blood       Date:  1992-07-15       Impact factor: 22.113

7.  Follicle-stimulating hormone induction of steel factor (SLF) mRNA in mouse Sertoli cells and stimulation of DNA synthesis in spermatogonia by soluble SLF.

Authors:  P Rossi; S Dolci; C Albanesi; P Grimaldi; R Ricca; R Geremia
Journal:  Dev Biol       Date:  1993-01       Impact factor: 3.582

8.  Modulation of cytostatic drugs by nifedipine in two heterotransplanted human testicular-cancer cell lines differing in their sensitivity to standard agents.

Authors:  C Bokemeyer; T Dunn; A Harstrick; T Lerch; H Poliwoda; H J Schmoll
Journal:  Int J Cancer       Date:  1994-02-01       Impact factor: 7.396

9.  Expression of the c-kit proto-oncogene and its ligand stem cell factor (SCF) in normal and malignant human testicular tissue.

Authors:  T Strohmeyer; D Reese; M Press; R Ackermann; M Hartmann; D Slamon
Journal:  J Urol       Date:  1995-02       Impact factor: 7.450

10.  Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand.

Authors:  Y Yarden; W J Kuang; T Yang-Feng; L Coussens; S Munemitsu; T J Dull; E Chen; J Schlessinger; U Francke; A Ullrich
Journal:  EMBO J       Date:  1987-11       Impact factor: 11.598

View more
  15 in total

1.  Expression of EGFR, HER-2/neu and KIT in germ cell tumours.

Authors:  Ignacio Durán; Adelaida García-Velasco; Claudio Ballestín; Elena García; Francisco Martínez-Tello; Gregory R Pond; Rocío García-Carbonero; Hernán Cortés-Funés; Luis Paz-Ares
Journal:  Clin Transl Oncol       Date:  2010-06       Impact factor: 3.405

2.  Fibroblast growth factor receptor 3 is highly expressed in rarely dividing human type A spermatogonia.

Authors:  Kathrein von Kopylow; Hannah Staege; Wolfgang Schulze; Hans Will; Christiane Kirchhoff
Journal:  Histochem Cell Biol       Date:  2012-07-10       Impact factor: 4.304

3.  c-kit and its related genes in spermatogonial differentiation.

Authors:  Lei Zhang; Jiangjing Tang; Christopher J Haines; Huai L Feng; Liangxue Lai; Xiaoming Teng; Yibing Han
Journal:  Spermatogenesis       Date:  2011-07-01

Review 4.  Treatment of clinical stage I testicular cancer and a possible role for new biological prognostic parameters.

Authors:  C Bokemeyer; M A Kuczyk; J Serth; J T Hartmann; H J Schmoll; U Jonas; L Kanz
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

5.  Activating c-kit gene mutations in human germ cell tumors.

Authors:  Q Tian; H F Frierson; G W Krystal; C A Moskaluk
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

6.  Stage-specific localization and expression of c-kit in the adult human testis.

Authors:  Sreepoorna K Unni; Deepak N Modi; Shilpa G Pathak; Jayesh V Dhabalia; Deepa Bhartiya
Journal:  J Histochem Cytochem       Date:  2009-05-11       Impact factor: 2.479

Review 7.  Emerging Therapeutic Targets for Male Germ Cell Tumors.

Authors:  Christian Daniel Fankhauser; Friedemann Honecker; Jörg Beyer; Peter Karl Bode
Journal:  Curr Oncol Rep       Date:  2015-12       Impact factor: 5.075

8.  C-kit and its ligand stem cell factor: potential contribution to prostate cancer bone metastasis.

Authors:  Christoph Wiesner; Sanaa M Nabha; Emanuel Burck Dos Santos; Hamilto Yamamoto; Hong Meng; Sebastian W Melchior; Fernando Bittinger; Joachim W Thüroff; Robert L Vessella; Michael L Cher; R Daniel Bonfil
Journal:  Neoplasia       Date:  2008-09       Impact factor: 5.715

9.  KIT mutations are common in testicular seminomas.

Authors:  Kathleen Kemmer; Christopher L Corless; Jonathan A Fletcher; Laura McGreevey; Andrea Haley; Diana Griffith; Oscar W Cummings; Cecily Wait; Ajia Town; Michael C Heinrich
Journal:  Am J Pathol       Date:  2004-01       Impact factor: 4.307

10.  Metaplastic transformation of urinary bladder epithelium: effect on mast cell recruitment, distribution, and phenotype expression.

Authors:  F Aldenborg; R Peeker; M Fall; A Olofsson; L Enerbäck
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.